Cluenex
Log inStart free
All stocks · Financial Services · Specialty Insurance Brokerage

Ryan Specialty Holdings RYAN

Ryan Specialty Holdings scores good on business quality (7.0 of 10). Here is why, in plain words, and what our sealed record shows.

Last price$37.01Oct 10, 2026
Business qualityGood
Next earningsOct 29, 2026, after the close
Insiders, 90 daysSelling

Why it matters

  1. What Ryan Specialty Holdings does

    Ryan Specialty Holdings operates as a wholesale broker and managing general agent, designing specialized insurance solutions for brokers, agents, and insurance carriers. The firm expands its footprint through strategic acquisitions and specialized product lines, capturing complex risks traditional insurers avoid.

  2. What it does best

    Ryan Specialty dominates complex excess and surplus insurance underwriting, growing revenue at 21.3 percent annually. This positions it in the top decile of its sector for growth, far outpacing peers like Marsh with 10.3 percent growth.

  3. The main risk

    Pricing cycle pressure weighs on pricing power, threatening the margin expansion required to justify its premium valuation. Recent headlines highlight how softening rates directly pressure the specialized brokerage commissions that drive cash flow.

Quality, check by check

Scored against its own industry, from company filings.

ProfitabilityFair

Operating margin sits at 18.7 percent with a 35th percentile FCF margin. Margins lag peers like Brown & Brown at 28.4 percent, showing the business absorbs higher operating costs as it scales.

MoatFair

Specialized underwriting expertise locks in enterprise clients with complex risks traditional insurers cannot touch. Its sector rank in revenue growth sits at the 85th percentile, supported by proprietary broker relationships.

GrowthFast

Revenue growth hit 21.3 percent, driven by expansion in specialty insurance lines. This rate accelerates above historical periods, outpacing broader industry averages significantly.

Financial healthStrong

Debt-to-equity of 5.2x and interest coverage of 2.7x leave little margin for error, though free cash flow reached $493M. The balance sheet is getting softer as leverage climbs.

Insiders

Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.

2 sold $1.7M outside pre-planned sales.

Our sealed record on RYAN

Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.

The first sealed verdicts appear here on Oct 11, 2026.

Questions

Is RYAN a good business?

Ryan Specialty Holdings scores good on the Cluenex quality check (7.0 of 10), measured against its own industry. Profitability is fair, moat fair, growth fast and financial health strong.

Are insiders buying RYAN?

In the last 90 days of SEC Form 4 filings: 2 sold $1.7M outside pre-planned sales.

When does RYAN report earnings?

Oct 29, 2026, after the close.

For members

See RYAN today

  • Today's verdict on RYAN, and why
  • Fair value with cautious, base and optimistic cases
  • The exact price that would change the verdict
  • Which stocks each signal names, the night it fires
Open in Cluenex Free to start. First month of Core free.

Cite this page: Cluenex, “Ryan Specialty Holdings (RYAN)”, https://cluenex.com/stocks/ryan/, data as of Oct 10, 2026.